![Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA](https://ifpma.org/wp-content/uploads/2023/01/i2023_NTD.png)
Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA
Joint research identifies hit compounds for the development of a new treatment for malaria Mitsubishi Tanabe Pharma uses its com
![Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery](https://media.springernature.com/w300/springer-static/image/art%3A10.1038%2Fnrd4683/MediaObjects/41573_2015_Article_BFnrd4683_Figa_HTML.jpg)
Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery
![Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University](https://ghss.georgetown.edu/wp-content/uploads/sites/285/2019/10/idconflict.png)
Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University
![What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo](https://www.daiichisankyo.com/files/news/ourstories/images/2211_ghitinterview/takahashi-san.webp?547)
What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo
![GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases](https://mma.prnewswire.com/media/1944149/GHIT_logo_Logo.jpg?p=facebook)
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases
![GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases](https://mma.prnewswire.com/media/1944150/GHIT_Portfolio_Analysis_Graph.jpg?p=facebook)